Translational Research in Malignancy Members
The Translational Research in Malignancy (TRIM) program is a highly interactive translational cancer research program. Its main objective is to conduct studies centered on molecular mechanisms of cancer progression and therapeutic resistance and to translate basic science and preclinical discoveries into early diagnosis, biomarkers, and cancer therapeutics.
Yang, Ximing
Professor
Bio
General Surgical Pathology and Urological Surgical Pathology Diagnosis of genital urinary cancers including prostate, bladder, kidney, testis and other GU organs Immunohistochemistry Pathogenesis of p... [more]
Yue, Feng
Professor
Bio
The long-term goal of Dr. Yue's group is to use a combination of high throughput genomics, computational modeling, and functional assays to study how genetic variants contribute to the pathogenes... [more]